2010Zhongguo yiyuan yongyao pingjia yu fenxiRequires access

Clinical Efficacy of Leflunomide for Rheumatoid Arthritis

Qiu Jin

Open publisher page 0 citations

Abstract

OBJECTIVE: To evaluate the clinical efficacy and safety of leflunomide for rheumatoid arthritis. METHODS: A total of 120 patients with rheumatoid arthritis were randomly divided into two groups of 60 each: the intervention group was treated with leflunomide and the control group was treated with methotrexate. The clinical effect and adverse reactions in the two groups were followed and compared. RESULTS: The intervention group showed better efficacy than in the control group,and the differences were significant (P 0. 05). CONCLUSION: Leflunomide has been shown to improve patients’condition with good clinical efficacy and safety,and it is thus an active drug for rheumatoid arthritis.

About this research paper

What this paper is about

OBJECTIVE: To evaluate the clinical efficacy and safety of leflunomide for rheumatoid arthritis. METHODS: A total of 120 patients with rheumatoid arthritis were randomly divided into two groups of 60 each: the intervention group was treated with leflunomide and the control group was treated with methotrexate. The clinical effect and adverse reactions in the two groups were followed and compared. RESULTS: The intervention group showed better efficacy than in the control group,and the differences were significant (P 0. 05). CONCLUSION: Leflunomide has been shown to improve patients’condition with good clinical efficacy and safety,and it is thus an active drug for rheumatoid arthritis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE: To evaluate the clinical efficacy and safety of leflunomide for rheumatoid arthritis. METHODS: A total of 120 patients with rheumatoid arthritis were randomly divided into two groups of 60 each: the intervention group was treated with leflunomide and the control group was treated with methotrexate. The clinical effect and adverse reactions in the two groups were followed and compared. RESULTS: The intervention group showed better efficacy than in the control group,and the differences were significant (P 0. 05). CONCLUSION: Leflunomide has been shown to improve patients’condition with good clinical efficacy and safety,and it is thus an active drug for rheumatoid arthritis.

Key concepts: Leflunomide, Rheumatoid arthritis, Medicine, Methotrexate, Clinical efficacy, Internal medicine, Arthritis, Adverse effect

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Efficacy of Leflunomide for Rheumatoid Arthritis — Research Paper | ScholarLens